Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9625)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yim HJ, Suh SJ, Um SH. Current management of hepatocellular carcinoma: An Eastern perspective. World J Gastroenterol 2015; 21(13): 3826-3842 [PMID: 25852267 DOI: 10.3748/wjg.v21.i13.3826] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i13/3826.htm |
| Number | Citing Articles |
| 1 |
Hua Ding, Zhi-Hua Ye, Dong-Yue Wen, Xiao-Liang Huang, Chu-Mei Zeng, Jie Mo, Yi-Qiang Jiang, Jian-Jun Li, Xiao-Yong Cai, Hong Yang, Gang Chen. Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significance. Molecular Medicine Reports 2017; 16(4): 5393 doi: 10.3892/mmr.2017.7275
|
| 2 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
| 3 |
Feng-Qin Zhang, Lin Li, Ping-Chao Huang, Yu-Fei Fu, Qing-Song Xu. Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis. Minimally Invasive Therapy & Allied Technologies 2022; 31(5): 676 doi: 10.1080/13645706.2021.1986724
|
| 4 |
Valentina Bianchi, Erida Nure, Carmen Nesci, Marco Maria Pascale, Gabriele Sganga, Salvatore Agnes, Giuseppe Brisinda. Bridge Therapy before Liver Transplant for Advanced Hepatocellular Carcinoma. Medicina 2024; 60(6): 1010 doi: 10.3390/medicina60061010
|
| 5 |
Silvia Brocco, Anna Sara Fraia, Anna Florio, Emilio Quaia. Imaging of the Liver and Intra-hepatic Biliary Tract. Medical Radiology 2021; : 349 doi: 10.1007/978-3-030-39021-1_15
|
| 6 |
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy. Livers 2023; 3(1): 121 doi: 10.3390/livers3010011
|
| 7 |
Wei Li, Yu-Hong Tian, Ying Liu, Zi Wang, Shan Tang, Jing Zhang, Ying-Ping Wang. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis. The Journal of Toxicological Sciences 2016; 41(3): 417 doi: 10.2131/jts.41.417
|
| 8 |
Min Li, Mao Zhang, Zhi-lang Zhang, Ning Liu, Xiao-yu Han, Qin-cheng Liu, Wei-jun Deng, Cai-xian Liao. Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(2): 233 doi: 10.3727/096504016X14742891049073
|
| 9 |
Jie-Yu Kong, Shu-Mei Li, Hai-Yan Fan, Lan Zhang, Hui-Jin Zhao, Sheng-Mian Li. Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma. Medicine 2018; 97(33): e11872 doi: 10.1097/MD.0000000000011872
|
| 10 |
Xuesong Yao, Dong Yan, Huiying Zeng, Dengzhong Liu, Huai Li. Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma. Journal of Surgical Oncology 2016; 113(6): 672 doi: 10.1002/jso.24215
|
| 11 |
Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee. Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study. PLOS ONE 2019; 14(10): e0223678 doi: 10.1371/journal.pone.0223678
|
| 12 |
Min Deng, Rongce Zhao, Renguo Guan, Shaohua Li, Zhijun Zuo, Wenping Lin, Wei Wei, Rongping Guo. Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01310-4
|
| 13 |
Junwei Chen, Lisha Lai, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10361-5
|
| 14 |
Ying Sun, Yu-jun Tan, Zhan-zhao Lu, Bing-bing Li, Cheng-hong Sun, Tao Li, Li-li Zhao, Zhong Liu, Gui-min Zhang, Jing-chun Yao, Jie Li. Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00268
|
| 15 |
Yuan‐Hung Kuo, Jing‐Houng Wang, Chao‐Hung Hung, Kun‐Ming Rau, I‐Pei Wu, Chien‐Hung Chen, Kwong‐Ming Kee, Tsung‐Hui Hu, Sheng‐Nan Lu. Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use. Journal of Gastroenterology and Hepatology 2017; 32(12): 1975 doi: 10.1111/jgh.13783
|
| 16 |
Kenan Hao, Jincheng Li, Youao Zhang, Wei Zhao, Xiaojing Chen, Jiabin Xu, Ye Tian, Xinmin Li, Jianyu Fen, Xiaofeng He. Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(8): 4429 doi: 10.1007/s00432-022-04338-x
|
| 17 |
Min Deng, Qiucheng Lei, Jiamin Wang, Carol Lee, Renguo Guan, Shaohua Li, Wei Wei, Huanwei Chen, Chong Zhong, Rongping Guo. Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study. International Journal of Surgery 2023; 109(5): 1299 doi: 10.1097/JS9.0000000000000376
|
| 18 |
Jia-yan Ni, Jian Kong, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Dong Chen, Xiong-ying Jiang, Lin-feng Xu. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas. Academic Radiology 2018; 25(4): 423 doi: 10.1016/j.acra.2017.10.018
|
| 19 |
Takuji Torimura, Hideki Iwamoto. Treatment and the prognosis of hepatocellular carcinoma in Asia. Liver International 2022; 42(9): 2042 doi: 10.1111/liv.15130
|
| 20 |
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
|
| 21 |
Chaoyong Tu, Wei Chen, Shuqian Wang, Wei Tan, Jingqiang Guo, Chuxiao Shao, Weilin Wang. MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2. Journal of Cellular and Molecular Medicine 2019; 23(11): 7190 doi: 10.1111/jcmm.14197
|
| 22 |
Zhiming Zhang, Gaoxiong Ouyang, Peng Wang, Yuan Ren, Yukai Liu, Jun Chen, Yumei Zhang, Jianyong Liu, Lequn Li. Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01065-x
|
| 23 |
Hideaki Takeyama, Toru Beppu, Takaaki Higashi, Takayoshi Kaida, Kota Arima, Katsunobu Taki, Katsunori Imai, Hidetoshi Nitta, Hiromitsu Hayashi, Shigeki Nakagawa, Hirohisa Okabe, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Motohiko Tanaka, Yutaka Sasaki, Hideo Baba. Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma. Surgery Today 2018; 48(4): 431 doi: 10.1007/s00595-017-1603-x
|
| 24 |
Zhihong Wang, Hong Ji, Qiong Qiu, Jianlan Wang. Role of serum lactate dehydrogenase levels in evaluating efficacy of interventional therapy for hepatocellular carcinoma. Oncology and Translational Medicine 2018; 4(6): 238 doi: 10.1007/s10330-018-0299-9
|
| 25 |
Wei Wang, Yang Wang, Mingxing Liu, Yifan Zhang, Tao Yang, Dongsheng Li, Yinpeng Huang, Qing Li, Guang Bai, Linlin Shi. Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivo. Journal of Cellular and Molecular Medicine 2019; 23(1): 586 doi: 10.1111/jcmm.13964
|
| 26 |
Shi-Yan Yan, Yi Zhang, Chao Sun, Hai-Xia Cao, Guang-Ming Li, Yu-Qin Wang, Jian-Gao Fan. The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinoma. Oncology Letters 2016; 12(2): 951 doi: 10.3892/ol.2016.4694
|
| 27 |
Young Eun Ahn, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Tae Hyung Kim, Young Sun Lee, Sun Young Yim, Hae Rim Kim, Seong Hee Kang, Young Kul Jung, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and Liver 2021; 15(2): 284 doi: 10.5009/gnl19367
|
| 28 |
E-Na Qian, Shuang-Yin Han, Song-Ze Ding, Xun Lv. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma. Cancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0332-3
|
| 29 |
Jan Lerut. Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?. Hepatobiliary & Pancreatic Diseases International 2024; 23(2): 111 doi: 10.1016/j.hbpd.2023.12.001
|
| 30 |
Luyang Wang, Le Tong, Zecheng Xiong, Yi Chen, Ping Zhang, Yan Gao, Jing Liu, Lei Yang, Chunqi Huang, Gaoqi Ye, Jing Du, Huibiao Liu, Wei Yang, Ying Wang. Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02808-7
|
| 31 |
Dirk J. van Leeuwen, Otto M. van Delden. Ethics and informed consent in patients with hepatocellular carcinoma: Changing roles for hepatologist and radiologist. Clinical Liver Disease 2015; 6(5): 122 doi: 10.1002/cld.513
|
| 32 |
Tianfan Pan, Feng Gao, Xiangzhong Huang, Xinjian Xu. Transarterial embolization followed by staged hepatectomy versus emergency hepatectomy for ruptured HCC: a meta-analysis. Clinical and Translational Oncology 2023; 26(1): 155 doi: 10.1007/s12094-023-03232-3
|
| 33 |
Teerapat Ungtrakul, Chulabhorn Mahidol, Pattra Chun-on, Charlie Laohapand, Surachate Siripongsakun, Akeanong Worakitsitisatorn, Sirachat Vidhayakorn, Wariya Boonchuay, Jiraporn Dechma, Gaidganok Sornsamdang, Kamonwan Soonklang, Tassanee Sriprayoon, Tawesak Tanwandee, Chirayu U Auewarakul. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. World Journal of Gastroenterology 2016; 22(34): 7806-7812 doi: 10.3748/wjg.v22.i34.7806
|
| 34 |
XIAO-XI KAN, QI LI, XI CHEN, YA-JIE WANG, YU-JIE LI, QING YANG, HONG-BIN XIAO, ZHI-XIN WANG, YING CHEN, XIAO-GANG WENG, WEI-YAN CAI, XIAO-XIN ZHU. A novel cell cycle blocker extracted from Stellera chamaejasme L. inhibits the proliferation of hepatocarcinoma cells. Oncology Reports 2016; 35(6): 3480 doi: 10.3892/or.2016.4742
|
| 35 |
Mohamed M. Tawfik, Nourhan Eissa, Fayez Althobaiti, Eman Fayad, Ali H. Abu Almaaty. Nomad Jellyfish Rhopilema nomadica Venom Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Hepatocellular Carcinoma HepG2 Cells. Molecules 2021; 26(17): 5185 doi: 10.3390/molecules26175185
|
| 36 |
Lujun Shen, Mian Xi, Lei Zhao, Xuhui Zhang, Xiuchen Wang, Zhimei Huang, Qifeng Chen, Tianqi Zhang, Jingxian Shen, Mengzhong Liu, Jinhua Huang. Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib. Cancers 2018; 10(12): 516 doi: 10.3390/cancers10120516
|
| 37 |
Gao-Xiong Ouyang, Yu-mei Zhang, Shao-Liang Zhu, Peng Wang, Yuan Ren, Jia-Hao Li, Yu-Kai Liu, Jun Chen, Bang-De Xiang, Le-Qun Li, Jian-Yong Liu, Zhi-Ming Zhang. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31351-3
|
| 38 |
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy. Journal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
|
| 39 |
Wafaa M. Rashed, Mohamed Ahmed Mohamed Kandeil, Mohamed O. Mahmoud, Sameera Ezzat. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. Journal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-0016-x
|
| 40 |
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC. Microbial Pathogenesis 2017; 109: 49 doi: 10.1016/j.micpath.2017.04.028
|
| 41 |
Hoon Sik Choi, Ki Mun Kang, Bae Kwon Jeong, Hojin Jeong, Yun Hee Lee, In Bong Ha, Jin Ho Song. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease. Asia-Pacific Journal of Clinical Oncology 2021; 17(3): 209 doi: 10.1111/ajco.13361
|
| 42 |
Minghui Zhou, Shuang Li, Sheng Shi, Shaolong He, Yanni Ma, Wenping Wang.
Hepatic targeting of glycyrrhetinic acid
via
nanomicelles based on stearic acid-modified fenugreek gum
. Artificial Cells, Nanomedicine, and Biotechnology 2020; 48(1): 1105 doi: 10.1080/21691401.2020.1813740
|
| 43 |
Chi-Yuan Chen, Jia-You Fang, Chin-Chuan Chen, Wen-Yu Chuang, Yann-Lii Leu, Shir-Hwa Ueng, Li-Shan Wei, Shu-Fang Cheng, Chuen Hsueh, Tong-Hong Wang. 2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase Expression. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01319
|
| 44 |
Yichen Yang, Yuequn Ma, Meng Yuan, Yonglin Peng, Zhonghai Fang, Ju Wang. Identifying the biomarkers and pathways associated with hepatocellular carcinoma based on an integrated analysis approach. Liver International 2021; 41(10): 2485 doi: 10.1111/liv.14972
|